reports hero background
Updated: Nov 22, 2026
SGP Logo

SpyGlass Pharma

NASDAQ:SGP·Stock Analysis Report
Day Range
$29.07 - $31.73
Market Cap
1.03B
P/E Ratio
0.0000
Avg Value
$28.49
Year Range
$17.06 - $39.92
$30.43-$0.35 (-1.14%)
1
General Information
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines.

The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

2
SpyGlass Pharma (SGP) Stock Graph
3
How We Grade SpyGlass Pharma (SGP)

We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.

The chart below shows how we grade SpyGlass Pharma (SGP) across the board compared to its closest peers.

4
Benzinga Edge Rankings

Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.

5
Peer Ratings

See how SpyGlass Pharma compares to its peers in these key performance metrics from Benzinga Rankings.

Top Peers
Value
Quality
Growth
Momentum
Short
Medium
Long
OMEROmeros
N/A
N/A
N/A
90.8
ANROAlto Neuroscience
N/A
N/A
N/A
93.78
SPTXSeaport Therapeutics
N/A
N/A
N/A
N/A
CRONCronos Group
55.2
N/A
55.39
86.6
Short: price trend over the last couple of months
Medium: price trend over the last couple of quarters
Long: price trend over the past year
Stock Score Locked: Want to See it?
Benzinga Edge Rankings give you vital metrics on any stock – anytime.
6
Future Growth
Our estimate of future price growth is based on an aggregation of 5 analyst ratings over the past 3 months and their 12-month price targets.

Below, you can see that analysts are estimating a 12-month price target range of $37.00 - $45.00 with an average of $41.20

34.68%
Expected movement for SpyGlass Pharma (SGP) over the next 12 months
Based on these rankings

Recent Ratings for SpyGlass Pharma (SGP)

Citigroup
Date:
Nov 13, 2026
Action:
Maintains
Prev. Target:
$42.00
New Target:
$45.00
Stifel
Date:
Nov 13, 2026
Action:
Maintains
Prev. Target:
$42.00
New Target:
$44.00
HC Wainwright & Co.
Date:
Nov 12, 2026
Action:
Maintains
Prev. Target:
$37.00
New Target:
$43.00
HC Wainwright & Co.
Date:
Oct 21, 2026
Action:
Reiterates
Prev. Target:
$37.00
New Target:
$37.00
HC Wainwright & Co.
Date:
Oct 5, 2026
Action:
Reiterates
Prev. Target:
$37.00
New Target:
$37.00
7
Past Performance
How has SpyGlass Pharma (SGP) performed over the past 5 years?

The two main factors that we consider when analyzing past performance is overall return and volatility

Using these two metrics, we can determine if this stock gave its investors enough return for the risk that they took on by owning it. This is measured by the sharpe ratio, which has been used as a primary measure of risk/reward trade-off for almost 60 years.

This ratio can be interpreted as the amount of return an investor has received for the amount of risk that they took on by owning the stock over that timeframe.

SpyGlass Pharma (SGP) sharpe ratio over the past 5 years is 0.0859 which is considered to be above average compared to the peer average of -0.1912